These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 1016972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC.
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].
    Kleeberg UR, Schreml W.
    Dtsch Med Wochenschr; 1976 Jun 04; 101(23):890-4. PubMed ID: 1269431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of metastatic malignant melanoma (author's transl)].
    Kühböck J, Pehamberger H, Mach K, Diem E, Kokoschka EM, Pötzi P.
    Wien Klin Wochenschr; 1978 Dec 22; 90(24):856-8. PubMed ID: 84441
    [Abstract] [Full Text] [Related]

  • 9. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
    Carbone PP, Costello W.
    Cancer Treat Rep; 1976 Feb 22; 60(2):193-8. PubMed ID: 769973
    [Abstract] [Full Text] [Related]

  • 10. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL.
    Cancer Treat Rep; 1976 Feb 22; 60(2):165-76. PubMed ID: 769969
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH, Furnas B.
    Cancer Treat Rep; 1977 Aug 22; 61(5):881-3. PubMed ID: 329981
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chemotherapy of malignant melanoma].
    Wagenknecht L.
    Schweiz Med Wochenschr; 1973 Oct 13; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract] [Full Text] [Related]

  • 14. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK, Baker LH, Izbicki RM, Ratanatharathorn V.
    Cancer Treat Rep; 1976 Sep 13; 60(9):1369-71. PubMed ID: 65223
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
    Cohen SM, Greenspan EM, Ratner LH, Weiner MJ.
    Cancer; 1977 Jan 13; 39(1):41-4. PubMed ID: 832250
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
    Moon JH, Gailani S, Cooper MR, Hayes DM, Rege VB, Blom J, Falkson G, Maurice P, Brunner K, Glidewell O, Holland JF.
    Cancer; 1975 Feb 13; 35(2):368-71. PubMed ID: 1111913
    [Abstract] [Full Text] [Related]

  • 19. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb 13; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 20. Clinical studies with DTIC (NSC-45388) in various malignancies.
    Slavik M.
    Cancer Treat Rep; 1976 Feb 13; 60(2):213-4. PubMed ID: 769976
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.